Back to Search

ZHENG (GEORGE) LIU, MD

MD

Clinical Pathology/Laboratory Medicine Physician

NPI: 1841210952IndividualAccepts Medicare

Specialties, Licenses & Credentials

Anatomic Pathology & Clinical Pathology Physician

Pathology — Anatomic Pathology & Clinical Pathology

Code: 207ZP0102X

036103655(IL)
Clinical Pathology/Laboratory Medicine PhysicianPrimary

Pathology — Clinical Pathology/Laboratory Medicine

Code: 207ZP0105X

036103655(IL)

CMS Specialties

PrimaryPATHOLOGY

Education

OTHER

Class of 1983

Clinical Trials (1)

1
Linked Trials
1
Recruiting
0
With Results

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

NCT04575844RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
PMID 28237263·Lancet·2017
4-observational
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
PMID 27295427·N Engl J Med·2016
4-observational
Postexercise improvement in insulin-stimulated glucose uptake occurs concomitant with greater AS160 phosphorylation in muscle from normal and insulin-resistant rats.
PMID 24608437·Diabetes·2014
7-preclinical
Exercise-induced capillary growth in human skeletal muscle and the dynamics of VEGF.
PMID 24450403·Microcirculation·2014
6-review
Exercise, GLUT4, and skeletal muscle glucose uptake.
PMID 23899560·Physiol Rev·2013
6-review
GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.
PMID 23684008·Metabolism·2013
8-other
Exercise training and cardiometabolic diseases: focus on the vascular system.
PMID 23519745·Curr Hypertens Rep·2013
6-review
The vascular endothelium in diabetes and its potential as a therapeutic target.
PMID 23397463·Rev Endocr Metab Disord·2013
6-review
Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance.
PMID 23002035·Diabetes·2013
7-preclinical
Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.
PMID 21617098·Diabetes Care·2011
8-other
Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.
PMID 21610226·Am J Physiol Endocrinol Metab·2011
6-review
Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability.
PMID 21289242·J Clin Endocrinol Metab·2011
8-other
Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.
PMID 21047922·J Clin Endocrinol Metab·2011
2-rct
Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.
PMID 19996061·Hypertension·2010
4-observational
Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature.
PMID 19567533·J Clin Endocrinol Metab·2009
8-other
Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice.
PMID 19237429·J Physiol·2009
7-preclinical
Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
PMID 17823371·Circ Res·2007
7-preclinical
Hyperinsulinemia rapidly increases human muscle microvascular perfusion but fails to increase muscle insulin clearance: evidence that a saturable process mediates muscle insulin uptake.
PMID 17720897·Diabetes·2007
8-other
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
PMID 17711996·Am J Physiol Endocrinol Metab·2007
2-rct
Contraction stimulates nitric oxide independent microvascular recruitment and increases muscle insulin uptake.
PMID 17563063·Diabetes·2007
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
150 W HIGH ST
MORRIS, IL 60450

Locations (2)

Practice Location

150 W HIGH ST, MORRIS, IL
(815) 942-2932

Practice Location

611 W. PARK ST, URBANA, IL
(217) 383-3342

Quick Facts

NPI
1841210952
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
43
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile